Carlton Haywood, Jr., PhD

Assistant Professor


Welch Center for Prevention, Epidemiology, and Clinical Research
The John Hopkins Medical Institutions
2024 E. Monument Street
Suite 2-600
Baltimore, MD 21205
  • Core Faculty
    Berman Institute of Bioethics
  • Core Faculty
    Welch Center for Prevention, Epidemiology, and Clinical Research
  • Assistant Professor
    Division of Hematology, Johns Hopkins School of Medicine

Carlton Haywood Jr., PhD, MA, was a core faculty member at the Johns Hopkins Berman Institute of Bioethics, core faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research, and an assistant professor in the Division of Hematology at the Johns Hopkins School of Medicine. He passed away on Dec. 31, 2021. Read a memorial to our friend and colleague.

Dr. Haywood conducted empirical bioethics and health services research related to sickle cell disease. Additionally, Dr. Haywood was interested in the articulation of African American perspectives in bioethics. Dr. Haywood’s dissertation examined the association of patient-centered care with trust in the medical profession among adults with sickle cell disease. Dr. Haywood had a career development award (K01) from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes for Health (NIH) to continue his studies of trust among sickle cell patients.  Dr. Haywood’s dissertation and doctoral training were also funded by the NHLBI through a National Research Service Award.

Read More

Dr. Haywood’s professional activities included involvement in sickle cell initiatives at the state and federal level. Dr. Haywood serves on Maryland’s Statewide Steering Committee on Services for Adults with Sickle Cell Disease. At the federal level, Dr. Haywood served on a National Human Genome Research Institute sponsored working group charged with examining the evidence regarding the clinical implications of sickle cell carrier status. Dr. Haywood also served as a member of the oversight steering committee for the Health Resources and Services Administration’s Sickle Cell Disease Treatment Demonstration Program.

Dr. Haywood received his doctorate in bioethics and health policy from the Johns Hopkins Bloomberg School of Public Health. Dr. Haywood received his undergraduate degree in religious studies (1999), and his master’s degree in bioethics (2003), from the University of Virginia.

Research Interests

  • Articulation of African American perspectives in bioethics


  • B.A., Religious Studies, University of Virginia
  • Master’s, Bioethics, University of Virginia
  • Ph.D., Bioethics and Health Policy, Johns Hopkins Bloomberg School of Public Health

Recent Publications

1. Bediako, S. M., Lanzkron, S., Diener-West, M., Onojobi, G., Beach, M. C., & Haywood, C. (2014). The Measure of Sickle Cell Stigma: Initial findings from the Improving Patient Outcomes through Respect and Trust study. Journal of health psychology, 1359105314539530.

2. Haywood Jr, C., Bediako, S., Lanzkron, S., Diener-West, M., Strouse, J., Haythornthwaite, J., … & IMPORT Investigators. (2014). An unequal burden: Poor patient–provider communication and sickle cell disease. Patient education and counseling96(2), 159-164.

3. Haywood, C., Diener-West, M., Strouse, J., Carroll, C. P., Bediako, S., Lanzkron, S., … & IMPORT Investigators. (2014). Perceived discrimination in health care is associated with a greater burden of pain in sickle cell diseaseJournal of pain and symptom management48(5), 934-943.

4. Haywood, C., Lanzkron, S., Diener-West, M., Haythornthwaite, J., Strouse, J. J., Bediako, S., … & Beach, M. C. (2014).  Attitudes toward clinical trials among patients with sickle cell disease. Clinical Trials11(3), 275-283.

5. Elander, J., Beach, M. C., & Haywood Jr, C. (2011). Respect, trust, and the management of sickle cell disease pain in hospital: comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice. Ethnicity & health16(4-5), 405-421.

6. Dampier, C., Haywood, C., & Lantos, J. (2011). A “Narcotics Contract” for a Patient With Sickle Cell Disease and Chronic Pain. Pediatrics128(1), 127-131.

7. Carroll, C. P., Haywood, C., & Lanzkron, S. (2011). Prediction of onset and course of high hospital utilization in sickle cell disease. Journal of Hospital Medicine6(5), 248-255.

8. Butrick, M., Roter, D., Kaphingst, K., Erby, L. H., Haywood, C., Beach, M. C., & Levy, H. P. (2011). Patient reactions to personalized medicine vignettes: An experimental design. Genetics in Medicine13(5), 421-428.

9. Haywood Jr, C., Lanzkron, S., Hughes, M. T., Brown, R., Massa, M., Ratanawongsa, N., & Beach, M. C. (2011). A video-intervention to improve clinician attitudes toward patients with sickle cell disease: the results of a randomized experiment. Journal of general internal medicine26(5), 518-523.

10. Haywood, C., Beach, M. C., Bediako, S., Carroll, C. P., Lattimer, L., Jarrett, D., & Lanzkron, S. (2011). Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease. American journal of hematology86(1), 85-87.